Ara
Toplam kayıt 7, listelenen: 1-7
Emergence of Stuttering in an Attention Deficit Hyperactivity Disorder Patient Treated with Methylphenidate
(Düşünen Adam-Journal of Psychiatry and Neurological Sciences, 2018-06)
…
Trigeminal Nerve Stimulation: A Recently Approved Treatment Approach in Attention Deficit Hyperactivity Disorder
(Springer, 2021)
Attention-deficit hyperactivity disorder (ADHD) with its high prevalence is a growing area of concern and research, whereas exact underlying pathophysiology remains unknown. Behavioral therapy and multiple medications ...
New Perspectives in Attention Deficit Hyperactivity Disorder: Possible Link to Oxytocin
(Dr. Mladen Stojanovic University Hospital, 2021)
Çöpür, M., & Çöpür, S. (2021). New Perspectives in Attention Deficit Hyperactivity Disorder: Possible Link to Oxytocin. Archives of Psychiatry Research: An International Journal of Psychiatry and Related Sciences, 57(2), 189-192.
Olanzapine in the treatment of anorexia nervosa: a systematic review
(Springer, 2020)
Anorexia nervosa, with the highest mortality rate among psychiatric diseases, is characterized by low body mass index, fear of weight gain, and disturbed body image. Even though multiple drugs have been proposed for the ...
Risperidone and hepatotoxicity in children and adolescent: A literature review
(Cyprus Mental Health Institute, 2020)
Risperidone is a second generation anti-psychotic drug that is commonly preferred in the treatment of schizophrenia, attention deficit hyperactivity disorder and bipolar disorders. Risperidone-associated hepatic adverse ...
Bumetanide for autism spectrum disorder: Current evidence
(Klinik Psikiyatri Dergisi, 2020)
Bumetanide for autism spectrum disorder: Current evidence
Prioritization of Patients With Psychiatric Comorbidities in Vaccination During COVID-19 Pandemic
(ANP Publishing, 2022)
COVID-19 pandemisinde psikiyatrik komorbiditeleri olan hastaların
aşılamada önceliklendirilmesi